Simulations Plus Other Non-Current Liabilities 2010-2024 | SLP
Simulations Plus other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Simulations Plus Annual Other Non-Current Liabilities
(Millions of US $) |
| 2024 |
$ |
| 2023 |
$3 |
| 2022 |
$ |
| 2021 |
$ |
| 2020 |
$4 |
| 2019 |
$ |
| 2018 |
$3 |
| 2017 |
$6 |
| 2016 |
$ |
| 2015 |
$1 |
| 2014 |
$2 |
| 2013 |
$0 |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
Simulations Plus Quarterly Other Non-Current Liabilities
(Millions of US $) |
| 2024-08-31 |
|
| 2024-05-31 |
|
| 2024-02-29 |
$2 |
| 2023-11-30 |
$4 |
| 2023-08-31 |
$3 |
| 2023-05-31 |
|
| 2023-02-28 |
|
| 2022-11-30 |
|
| 2022-08-31 |
|
| 2022-05-31 |
|
| 2022-02-28 |
|
| 2021-11-30 |
|
| 2021-08-31 |
|
| 2021-05-31 |
$3 |
| 2021-02-28 |
$4 |
| 2020-11-30 |
$4 |
| 2020-08-31 |
$4 |
| 2020-05-31 |
$4 |
| 2020-02-29 |
|
| 2019-11-30 |
|
| 2019-08-31 |
|
| 2019-05-31 |
$2 |
| 2019-02-28 |
$2 |
| 2018-11-30 |
$2 |
| 2018-08-31 |
$3 |
| 2018-05-31 |
$3 |
| 2018-02-28 |
$3 |
| 2017-11-30 |
$3 |
| 2017-08-31 |
$6 |
| 2017-05-31 |
|
| 2017-02-28 |
|
| 2016-11-30 |
|
| 2016-08-31 |
|
| 2016-05-31 |
|
| 2016-02-29 |
$1 |
| 2015-11-30 |
$1 |
| 2015-08-31 |
$1 |
| 2015-05-31 |
$3 |
| 2015-02-28 |
$4 |
| 2014-11-30 |
$4 |
| 2014-08-31 |
$2 |
| 2014-05-31 |
$2 |
| 2014-02-28 |
$0 |
| 2013-11-30 |
$0 |
| 2013-08-31 |
$0 |
| 2013-05-31 |
|
| 2013-02-28 |
|
| 2012-11-30 |
|
| 2012-08-31 |
|
| 2012-05-31 |
|
| 2012-02-29 |
|
| 2011-11-30 |
|
| 2011-08-31 |
|
| 2011-05-31 |
|
| 2011-02-28 |
|
| 2010-11-30 |
|
| 2010-08-31 |
|
| 2010-05-31 |
|
| 2010-02-28 |
|
| 2009-11-30 |
|
| 2009-08-31 |
|
| 2009-05-31 |
|
| 2009-02-28 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.554B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
